FDA Orange Book
Generic for Synalar
Synalar contains fluocinolone acetonide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Synalar is fluocinolone acetonide. 6 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AT.
Run it in Rivvi
Map Synalar and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Synalar products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| cream, topical | 0.01% | Marketed (Rx) | AT | 2 | AT |
| cream, topical | 0.025% | Marketed (Rx) | AT | 2 | AT |
| cream, topical | 0.025% | Marketed (Rx) | AT | 2 | AT |
| ointment, topical | 0.025% | Marketed (Rx) | AT | 2 | AT |
| solution, topical | 0.01% | Marketed (Rx) | AT | 5 | AT |
NDA 012787, 013960, 015296, held by EUROFARMA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic fluocinolone acetonide
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| FOUGERA PHARMACEUTICALS INC | 088170 | AT (A-rated, therapeutically equivalent) | December 16, 1982 | 0.01% |
| FOUGERA PHARMACEUTICALS INC | 088169 | AT (A-rated, therapeutically equivalent) | December 16, 1982 | 0.025%, 0.025% |
| FOUGERA PHARMACEUTICALS INC | 088168 | AT (A-rated, therapeutically equivalent) | December 16, 1982 | 0.025% |
| FOUGERA PHARMACEUTICALS INC | 088167 | AT (A-rated, therapeutically equivalent) | December 16, 1982 | 0.01% |
| SUN PHARMA CANADA INC | 089124 | AT (A-rated, therapeutically equivalent) | September 11, 1985 | 0.01% |
| COSETTE PHARMACEUTICALS NC LABORATORIES LLC | 089526 | AT (A-rated, therapeutically equivalent) | July 26, 1988 | 0.01% |
| COSETTE PHARMACEUTICALS NC LABORATORIES LLC | 089524 | AT (A-rated, therapeutically equivalent) | July 26, 1988 | 0.025% |
| LUPIN INC | 206422 | AT (A-rated, therapeutically equivalent) | September 2, 2015 | 0.01% |
| CHARTWELL RX SCIENCES LLC | 209596 | AT (A-rated, therapeutically equivalent) | December 26, 2017 | 0.01% |
| COSETTE PHARMACEUTICALS NC LABORATORIES LLC | 210747 | AT (A-rated, therapeutically equivalent) | November 5, 2018 | 0.025%, 0.025% |
| ENCUBE ETHICALS PVT LTD | 209913 | AT (A-rated, therapeutically equivalent) | February 13, 2019 | 0.01% |
Synalar NDC codes
Questions
Is there a generic for Synalar?
Yes. The generic name for Synalar is fluocinolone acetonide. 6 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AT.
What is the generic name for Synalar?
The active ingredient in Synalar is fluocinolone acetonide, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Synalar and Fluocinolone Acetonide
- What is Fluocinolone Acetonide used for?FDA label uses
- Is Fluocinolone Acetonide a controlled substance?Federal schedule
- Generic for IluvienFDA Orange Book
- Generic for DermoticFDA Orange Book
- Generic for Derma-Smoothe/FSFDA Orange Book
- Corticosteroids listFDA drug class
- NDC 43538-900Synalar NDC record
- NDC 43538-910Synalar NDC record